The bone marrow niche keeps puzzling scientists in cancer and regenerative medicine. What elements constitute the niche and how it affects neighbor cells in different disease contexts remain to be a matter of debate and extensive investigation. The translational use of hematopoietic stem cells (HSCs) in transplantation biology poses a challenge, given the propensity of these cells to remain quiescent. Although the niche is a good candidate to exploit for reprogramming HSCs and controlling their expansion, new studies have added to its complexity. In 'Bench to Bedside', Paul S. Frenette and Yuya Kunisaki examine these studies to discuss how new players and their signals are involved in HSC maintenance and what the implications are for the development of HSC-based therapies. Among the alterations occurring in leukemias, metabolic events seem to foster cancer progression but may also be involved in cancer predisposition. Rushdia Z. Yusuf, Ying-Hua Wang and David T. Scadden peruse recent clinical and experimental studies that look at myelodysplastic syndromes and secondary leukemias and argue how metabolic changes in these cancers may not only be cell autonomous but also can emanate from the bone marrow stroma. Targeting this niche may open new avenues to reduce the risk for secondary leukemias in cancer survivors.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Single-cell analyses identify bioengineered niches for enhanced maintenance of hematopoietic stem cells
Nature Communications Open Access 09 August 2017
-
Dynamic equilibrium of heterogeneous and interconvertible multipotent hematopoietic cell subsets
Scientific Reports Open Access 06 June 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Brunstein, C.G. et al. Blood 116, 4693–4699 (2010).
Schofield, R. Blood Cells 4, 7–25 (1978).
Byrd, D.T. & Kimble, J. Semin. Cell Dev. Biol. 20, 1107–1113 (2009).
Scadden, D.T. Nature 441, 1075–1079 (2006).
Sugiyama, T., Kohara, H., Noda, M. & Nagasawa, T. Immunity 25, 977–988 (2006).
Méndez-Ferrer, S. et al. Nature 466, 829–834 (2010).
Yamazaki, S. et al. Cell 147, 1146–1158 (2011).
Ding, L., Saunders, T.L., Enikolopov, G. & Morrison, S.J. Nature 481, 457–462 (2012).
Pietras, E.M., Warr, M.R. & Passegue, E. J. Cell Biol. 195, 709–720 (2011).
Yamazaki, S. et al. Blood 113, 1250–1256 (2009).
Katayama, Y. et al. Cell 124, 407–421 (2006).
Broudy, V.C. Blood 90, 1345–1364 (1997).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kunisaki, Y., Frenette, P. The secrets of the bone marrow niche: Enigmatic niche brings challenge for HSC expansion. Nat Med 18, 864–865 (2012). https://doi.org/10.1038/nm.2825
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2825
This article is cited by
-
Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2V617F mutation
Annals of Hematology (2023)
-
Single-cell analyses identify bioengineered niches for enhanced maintenance of hematopoietic stem cells
Nature Communications (2017)
-
Dynamic equilibrium of heterogeneous and interconvertible multipotent hematopoietic cell subsets
Scientific Reports (2014)
-
Circadian rhythms in leukocyte trafficking
Seminars in Immunopathology (2014)
-
Natural history of mesenchymal stem cells, from vessel walls to culture vessels
Cellular and Molecular Life Sciences (2014)